Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mitsuya

Showing results (181-190 of 343) with videos related to

Pageof 35
Sort By:
British Journal of Urology|August 1, 1979
Weight estimation of benign prostatic adenoma with urethral pressure profileA Kondo, H Narita, T Otani, et al.
The Journal of Clinical Investigation|May 1, 1986
Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type IR Yarchoan, H G Guo, M Reitz, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugsM E Morgan, S C Chi, K Murakami, et al.
Biochemical Pharmacology|August 11, 1998
Role of the M2 subunit of ribonucleotide reductase in regulation by hydroxyurea of the activity of the anti-HIV-1 agent 2',3'-dideoxyinosineW Y Gao, B S Zhou, D G Johns, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosidesJ E Dahlberg, H Mitsuya, S B Blam, et al.
Journal of Virology|April 25, 2000
Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domainS Sei, Q E Yang, D O'Neill, et al.
The Journal of Pediatrics|July 1, 1993
High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapyR N Husson, T Shirasaka, K M Butler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type IS Matsushita, M Robert-Guroff, J Trepel, et al.
The Journal of Pediatrics|June 1, 1995
Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotypeR N Husson, Y Lan, E Kojima, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cellsT Shirasaka, S Chokekijchai, A Yamada, et al.
Pageof 35

Showing results (181-190 of 343) with videos related to

Sort By:
Pageof 35
British Journal of Urology|August 1, 1979
Weight estimation of benign prostatic adenoma with urethral pressure profileA Kondo, H Narita, T Otani, et al.
The Journal of Clinical Investigation|May 1, 1986
Alterations in cytotoxic and helper T cell function after infection of T cell clones with human T cell leukemia virus, type IR Yarchoan, H G Guo, M Reitz, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1992
Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugsM E Morgan, S C Chi, K Murakami, et al.
Biochemical Pharmacology|August 11, 1998
Role of the M2 subunit of ribonucleotide reductase in regulation by hydroxyurea of the activity of the anti-HIV-1 agent 2',3'-dideoxyinosineW Y Gao, B S Zhou, D G Johns, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1987
Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosidesJ E Dahlberg, H Mitsuya, S B Blam, et al.
Journal of Virology|April 25, 2000
Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domainS Sei, Q E Yang, D O'Neill, et al.
The Journal of Pediatrics|July 1, 1993
High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapyR N Husson, T Shirasaka, K M Butler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1986
Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type IS Matsushita, M Robert-Guroff, J Trepel, et al.
The Journal of Pediatrics|June 1, 1995
Vertical transmission of human immunodeficiency virus type 1: autologous neutralizing antibody, virus load, and virus phenotypeR N Husson, Y Lan, E Kojima, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cellsT Shirasaka, S Chokekijchai, A Yamada, et al.
Pageof 35